Structured evidence table for 5-HTP Sleep Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| 5-HTP Sleep Meta-Analysis | The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation tool. | 1 | Li J (2025) | Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. |
| 5-HTP Sleep Meta-Analysis | Sleep disorders are the most common non-motor symptoms in patients with Parkinson’s disease (PD) and can significantly impact quality of life. | 1 | Li J (2025) | Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. |
| 5-HTP Sleep Meta-Analysis | However, the pharmacological treatments for sleep disorders in patients with PD remain controversial. | 1 | Li J (2025) | Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. |
| 5-HTP Sleep Meta-Analysis | Background In patients with Inflammatory Bowel Disease (IBD), fatigue is a debilitating problem and may be associated with sleep disturbance, anxiety, depression, anemia, use of systemic steroids and active phase of the disease. | 4 | Morais T (2026) | PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW. |
| 5-HTP Sleep Meta-Analysis | In addition, fatigue also affects the working conditions of these patients, as it is associated with absenteeism and is a reason for time off work, surpassing medical appointments and abdominal pain. | 4 | Morais T (2026) | PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW. |
| 5-HTP Sleep Meta-Analysis | Fatigue symptoms have been reduced with the use of vedolizumab, upadacitinib and modafinil. | 4 | Morais T (2026) | PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW. |
Source documents